Searching for Solutions

Email: info@aapp.org Phone: 402-476-1677 Mailing: 8055 O Street Suite S113 Lincoln, NE 68510

The AAPP 2024 Annual Meeting included valuable insights for psychiatric providers. If you were unable to attend live, you still have the ability to purchase on-demand access to all of the recorded sessions! The price is $685 for Nonmembers and $550 for AAPP Members. Register Now for On-Demand Access!

Xylazine is a nonopioid veterinary anesthetic that is increasingly detected in the illicit drug supply across the United States. Among opioid-overdose deaths, there has been a dramatic increase in the presence of xylazine. It is now a common additive to substances like fentanyl, heroin and cocaine. Fentanyl Adulterated or Associated with Xylazine (FAAX) was declared an emerging threat on April 12, 2023 by the White House Office of National Drug Control Policy.

Breaking New Ground  Pushing the envelope, charting new territory, blazing trails… all are apt descriptors for AAPP Foundation in 2024 as we not only support our ongoing research and student grants but additionally partner with our parent association, the American Association of Psychiatric Pharmacists (AAPP), to launch the Outcomes Initiative Research Grant Program!

The AAPP Outcomes Initiative grant was awarded during AAPP 2024. In 2023, AAPP committed up to $500,000 to directly support multi-site research related to the impact of psychiatric pharmacists on patient care through the AAPP Foundation. In September of 2023, 6 pre-applications were received and evaluated by the taskforce. After multiple points of feedback, 2 finalists submitted their applications on April 1, 2024.

Research activities may encompass someone's entire role, represent only a small percentage, or be completed on discretionary efforts. Entry into research has many paths. While it may be formal for some (e.g., fellowship, PhD training) it may develop spontaneously from patient specific questions that arise in clinical practice. In academic settings, research may also be pedagogic in nature.

AAPP has pledged up to $500,000 to the AAPP Foundation to directly support multi-site studies of the impact of psychiatric pharmacists. The first AAPP Outcomes Initiative grant was awarded during AAPP 2024. AAPP continues to work hard to standardize and improve clinical research, and psychiatric pharmacists are encouraged to learn more about the upcoming research grant competition at AAPP 2025!

Stimulants (e.g., methylphenidate and amphetamine salts) are effective medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. This free toolkit is intended to provide an evidence-based guide for thoughtfully converting from one stimulant product formulation to another. The toolkit provides information in the following areas:

Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to Facilitating Change to Develop a Practice Position in Psychiatric Pharmacy.

Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to Impact on Team Well-Being.

Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to Job Description Templates.

Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to Behavioral Health Integration (BHI) Model of Care.

Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to "Incident to" Billing.

Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes.

The ultimate goal is that every patient with a psychiatric disorder, including substance use disorders, will have their medication therapy reviewed, optimized, and managed by a psychiatric pharmacist as part of a psychotropic stewardship team. In short, intentional efforts to have a Board Certified Psychiatric Pharmacist (BCPP) provide Comprehensive Medication Management (CMM) services to patients with psychiatric disorders will improve access, outcomes, and cost.

AAPP envisions a world where all individuals living with mental illness receive safe, appropriate, and effective treatment. To achieve that, it is important to promote practices that reflect the best current evidence available. Thus, over time, all content will either be updated or removed from the web site.